Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8032)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2014 (publication date) through Jun 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Lee SY. Current progress toward eradicating |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i6/1493.htm |
| Number | Citing Articles |
| 1 |
Hiroki Tanabe, Katsuyoshi Ando, Kiichi Sato, Takahiro Ito, Mitsuru Goto, Tomonobu Sato, Akihiro Fujinaga, Toru Kawamoto, Tatsuya Utsumi, Nobuyuki Yanagawa, Eiichiro Ichiishi, Takaaki Otake, Yutaka Kohgo, Yoshiki Nomura, Nobuhiro Ueno, Hiroko Sugano, Shin Kashima, Kentaro Moriichi, Mikihiro Fujiya, Toshikatsu Okumura. Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature. Digestive Diseases and Sciences 2017; 62(11): 3069 doi: 10.1007/s10620-017-4664-1
|
| 2 |
|
| 3 |
Sun-Young Lee. There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding. Gut and Liver 2015; 9(3) doi: 10.5009/gnl14499
|
| 4 |
K. D. Lee, T. Kayano, H. Nishiura. Dramatic shift in the epidemiology of peptic ulcer in Japan: the impact of Helicobacter pylori eradication therapy. Epidemiology and Infection 2022; 150 doi: 10.1017/S095026882100265X
|
| 5 |
Sung Eun Kim, Joo Ha Hwang. Management of Helicobacter pylori Infection: A Comparison between Korea and the United States. Gut and Liver 2022; 16(4): 503 doi: 10.5009/gnl210224
|
| 6 |
Ju Yup Lee, Kyung Sik Park. Optimal First-Line Treatment forHelicobacter pyloriInfection: Recent Strategies. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/9086581
|
| 7 |
Soichiro Sue, Yuichi Suzuki, Tomohiko Sasaki, Hiroaki Kaneko, Kuniyasu Irie, Kazuto Komatsu, Shin Maeda. Prospective Study of Vonoprazan-Based First-Line Triple Therapy with Amoxicillin and Metronidazole for Clarithromycin-Resistant Helicobacter pylori. Journal of Clinical Medicine 2023; 12(17): 5443 doi: 10.3390/jcm12175443
|
| 8 |
Da Hyun Jung, Jie-Hyun Kim, Hyun Soo Chung, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Yong Chan Lee, Ju-Seog Lee. Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis. PLOS ONE 2015; 10(4): e0124725 doi: 10.1371/journal.pone.0124725
|
| 9 |
Hee-Won Moon, Sun-Young Lee, Mina Hur, Yeo-Min Yun. Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. The Korean Journal of Internal Medicine 2018; 33(5): 893 doi: 10.3904/kjim.2016.353
|
| 10 |
Hyun Gyung Kwon, Sun-Young Lee, Ji Hye Kim, Sang Pyo Lee, Jeong Hwan Kim, In-Kyung Sung, Hyung Seok Park, Chan Sup Shim. Effect of Alcohol Consumption on Seroconversion in Helicobacter pylori-Seronegative Koreans. The Korean Journal of Medicine 2018; 93(3): 277 doi: 10.3904/kjm.2018.93.3.277
|
| 11 |
Tsogt-Ochir Byambajav, Namdag Bira, Gotov Choijamts, Duger Davaadorj, Boldbaatar Gantuya, Tserenchimed Sarantuya, Gidaagaya Sarantuya, Altangerel Enkhtsetseg, Dungubat Erdenetsogt, Adiyasuren Battulga, Tegshee Tserentogtokh, Takeshi Matsuhisa, Yoshio Yamaoka, Khasag Oyuntsetseg. Initial Trials With Susceptibility-Based and Empiric Anti-H. pylori Therapies in Mongolia. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00394
|
| 12 |
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research. 2016; : 519 doi: 10.1007/978-4-431-55936-8_23
|
| 13 |
Jens Walldorf, Tina Jähnert, Norman B Berman, Martin R Fischer. Using Foreign Virtual Patients With Medical Students in Germany: Are Cultural Differences Evident and Do They Impede Learning?. Journal of Medical Internet Research 2016; 18(9): e260 doi: 10.2196/jmir.6040
|
| 14 |
Kichul Yoon, Nayoung Kim. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication ofHelicobacter pylori. The Korean Journal of Gastroenterology 2018; 72(3): 104 doi: 10.4166/kjg.2018.72.3.104
|
| 15 |
Jie-Hyun Kim. The Diagnosis ofHelicobacter pyloriInfection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2014; 14(4): 233 doi: 10.7704/kjhugr.2014.14.4.233
|
| 16 |
|
| 17 |
Sintayehu Fekadu, Hizkel Engiso, Sisay Seyfe, Hisashi Iizasa, Ashebir Godebo, Serawit Deyno, Hironori Yoshiyama. Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02707-5
|
| 18 |
Susheela D. Biranjia-Hurdoyal, Sharmila P. Seetulsingh-Goorah, Emanuel F. Petricoin. Performances of Four Helicobacter pylori Serological Detection Kits Using Stool Antigen Test as Gold Standard. PLOS ONE 2016; 11(10): e0163834 doi: 10.1371/journal.pone.0163834
|
| 19 |
Suh Eun Bae, Kee Don Choi, Jaewon Choe, Seon Ok Kim, Hee Kyong Na, Ji Young Choi, Ji Yong Ahn, Kee Wook Jung, JeongHoon Lee, Do Hoon Kim, Hye‐Sook Chang, Ho June Song, Gin Hyug Lee, Hwoon‐Yong Jung. The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations. Helicobacter 2018; 23(2) doi: 10.1111/hel.12464
|
| 20 |
Hyun Woo Park, Seong Woo Jeon. Clinical Outcomes of Patients with Non-ulcer and Non-variceal Upper Gastrointestinal Bleeding: A Prospective Multicenter Study of Risk Prediction Using a Scoring System. Digestive Diseases and Sciences 2018; 63(12): 3253 doi: 10.1007/s10620-018-5255-5
|
| 21 |
Lynne V McFarland, Ying Huang, Lin Wang, Peter Malfertheiner. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy forHelicobacter pylorieradication and prevention of adverse events. United European Gastroenterology Journal 2016; 4(4): 546 doi: 10.1177/2050640615617358
|
| 22 |
Ji Min Choi, Sang Gyun Kim. Diagnosis and Treatment of <i>Helicobacter Pylori</i> Infection: Korean and Overseas Guidelines. The Korean Journal of Medicine 2015; 89(2): 157 doi: 10.3904/kjm.2015.89.2.157
|
| 23 |
N. Jimura, K. Fujii, Y. Higashi, T. Kanekura. Idiopathic thrombocytopenic purpura in a patient with IgG4-related disease. Clinical and Experimental Dermatology 2018; 43(8): 941 doi: 10.1111/ced.13688
|
| 24 |
Ki Young Huh, Hyewon Chung, Yu Kyong Kim, SeungHwan Lee, Siddharth Bhatia, Yohei Takanami, Ryou Nakaya, Kyung‐Sang Yu. Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. British Journal of Clinical Pharmacology 2022; 88(1): 138 doi: 10.1111/bcp.14934
|
| 25 |
Hiroki Tanabe, Keiichi Yoshino, Katsuyoshi Ando, Yoshiki Nomura, Katsuhisa Ohta, Kiichi Satoh, Eiichiro Ichiishi, Akiei Ishizuka, Takaaki Otake, Yutaka Kohgo, Mikihiro Fujiya, Toshikatsu Okumura. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. Annals of Clinical Microbiology and Antimicrobials 2018; 17(1) doi: 10.1186/s12941-018-0281-x
|
| 26 |
|
| 27 |
Sun-Young Lee, Hee-Won Moon, Mina Hur, Yeo-Min Yun. Validation of western Helicobacter pylori IgG antibody assays in Korean adults.
Journal of Medical Microbiology
2015; 64(5): 513 doi: 10.1099/jmm.0.000050
|
| 28 |
Mehmet Mihmanli, Enver Ilhan, Ufuk Oguz Idiz, Ali Alemdar, Uygar Demir. Recent developments and innovations in gastric cancer. World Journal of Gastroenterology 2016; 22(17): 4307-4320 doi: 10.3748/wjg.v22.i17.4307
|
| 29 |
Muhammad Miftahussurur, Yoshio Yamaoka. Diagnostic Methods ofHelicobacter pyloriInfection for Epidemiological Studies: Critical Importance of Indirect Test Validation. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/4819423
|
| 30 |
Y. S. Jung, E. H. Kim, C. H. Park. Systematic review with meta‐analysis: the efficacy of vonoprazan‐based triple therapy on Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2017; 46(2): 106 doi: 10.1111/apt.14130
|
| 31 |
|
| 32 |
Yi-Chia Lee, Tsung-Hsien Chiang, Jyh-Ming Liou, Hsiu-Hsi Chen, Ming-Shiang Wu, David Y Graham. Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations. Gut and Liver 2016; 10(1): 12 doi: 10.5009/gnl15091
|
| 33 |
Shinzo Hiroi, Kentaro Sugano, Shiro Tanaka, Koji Kawakami. Impact of health insurance coverage forHelicobacter pylorigastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. BMJ Open 2017; 7(7): e015855 doi: 10.1136/bmjopen-2017-015855
|
| 34 |
Mi Kyung Chung, Hye Sung Kim, Jong Min Park, Eun Hee Kim, Young Min Han, Sung Hun Kwon, Kun Young Park, Ki Baik Hahm. Helicobacter pyloriInfection and Food Intervention for Preventing Associated Gastric Diseases Including Gastric Cancer. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2014; 14(4): 225 doi: 10.7704/kjhugr.2014.14.4.225
|
| 35 |
|
| 36 |
Ji Hye Kim, Sun-Young Lee, Hyun Gyung Kwon, Sang Pyo Lee, Jeong Hwan Kim, In-Kyung Sung, Hyung Seok Park, Chan Sup Shim. Serological Changes after EquivocalHelicobacter pylori-serology Test Findings Dependent on Gastric Secreting Ability. Korean Journal of Gastroenterology 2017; 70(4): 181 doi: 10.4166/kjg.2017.70.4.181
|
| 37 |
Qinglong Hu, Yizhuo Zhang, Xiaoyan Zhang, Kai Fu. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomarker Research 2016; 4(1) doi: 10.1186/s40364-016-0068-1
|
| 38 |
Woo Yul Lee, EunSil Oh, Mengqi Cui, Choon Ok Kim, Yeji Lim, Hunam Kim, Hyeonsoo Park, Sukyong Yoon, Min Soo Park, Taegon Hong. Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects. Translational and Clinical Pharmacology 2020; 28(1): 55 doi: 10.12793/tcp.2020.28.e5
|
| 39 |
|